Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Stopping minoxidil treatment resumes balding; continuous use needed for results.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Dogs exposed to their owners' hormone therapy developed hair loss, but symptoms resolved after stopping the therapy.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Hair loss in men is common, treatable, but not curable.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.